Aspire Private Capital’s QuidelOrtho QDEL Stock Holding History

Aspire Private Capital’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41	Closed	-$5K	–	622
2021 Q1	$5K	Buy	+41	New	+$7.57K	﹤0.01%	386

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Aspire Private Capital's QDEL Position: Q2 2021 in Review

Aspire Private Capital sold out of QuidelOrtho (QDEL) in Q2 2021, closing a stake of 41 shares — an estimated $5K sold.

Aspire Private Capital first reported a position in QDEL in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 331 funds tracked by Wall St. Rank hold QDEL as of Q2 2021.

Aspire Private Capital reported no remaining QuidelOrtho position as of Q2 2021 after selling out during the quarter.
Aspire Private Capital sold 41 QuidelOrtho shares in Q2 2021, an estimated $5K.
Aspire Private Capital first reported a position in QuidelOrtho in Q1 2021 and held it in 1 quarter.
Aspire Private Capital's QuidelOrtho position peaked at $5K in Q1 2021.
331 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2021.

Based on Aspire Private Capital's 13F filing for Q2 2021, filed 9 Aug 2021.